Archives of Clinical Infectious Diseases

Published by: Kowsar

Prevalence of Candida Infection at the Intensive Care Unit with Nested Polymerase Chain Reaction (PCR) Using Primer Mixes Specific to Candida DNA Topoisomerase II Genes

Mohammad Rahbar 1 , 2 , Sahar Vossoghian 3 , Shadi Alimehr 3 , Hamideh Shekari Ebrahim Abad 3 , Mona Mohammadzadeh 2 , Fatemeh Fallah 3 , * , Sedigheh Rafiei Tabatabaei 3 , Ehsan Khodadadi 4 and Mahnaz Saremi 1
Authors Information
1 Department of Microbiology, Iranian Reference Health Laboratory Research Center, Ministry of Health and Medical Education, Tehran, IR Iran
2 Department of Microbiology, Central Laboratory, Milad Hospital, Tehran, IR Iran
3 Pediatric Infections Research Center, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran
4 Department of Agronomy and Plant Breeding, Tabriz Branch, Islamic Azad University, Tabriz, IR Iran
Article information
  • Archives of Clinical Infectious Diseases: October 01, 2016, 11 (4); e36166
  • Published Online: August 17, 2016
  • Article Type: Research Article
  • Received: January 10, 2016
  • Revised: July 31, 2016
  • Accepted: August 2, 2016
  • DOI: 10.5812/archcid.36166

To Cite: Rahbar M, Vossoghian S, Alimehr S, Shekari Ebrahim Abad H, Mohammadzadeh M, et al. Prevalence of Candida Infection at the Intensive Care Unit with Nested Polymerase Chain Reaction (PCR) Using Primer Mixes Specific to Candida DNA Topoisomerase II Genes, Arch Clin Infect Dis. 2016 ; 11(4):e36166. doi: 10.5812/archcid.36166.

Copyright © 2016, Infectious Diseases and Tropical Medicine Research Center. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
  • 1. Rees JR, Pinner RW, Hajjeh RA, Brandt ME, Reingold AL. The epidemiological features of invasive mycotic infections in the San Francisco Bay area, 1992-1993: results of population-based laboratory active surveillance. Clin Infect Dis. 1998; 27(5): 1138-47[PubMed]
  • 2. Beck-Sague CM, Jarvis WR. Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980-1990. J Infect Dis. 1993; : 1247-51
  • 3. Pfaller MA, Jones RN, Doern GV, Sader HS, Messer SA, Houston A, et al. Bloodstream infections due to Candida species: SENTRY antimicrobial surveillance program in North America and Latin America, 1997-1998. Antimicrob Agents Chemother. 2000; 44(3): 747-51[PubMed]
  • 4. Xafranski H, Melo AS, Machado AM, Briones MR, Colombo AL. A quick and low-cost PCR-based assay for Candida spp. identification in positive blood culture bottles. BMC Infect Dis. 2013; 13: 467[DOI][PubMed]
  • 5. Marol S, Yucesoy M. Molecular epidemiology of Candida species isolated from clinical specimens of intensive care unit patients. Mycoses. 2008; 51(1): 40-9[DOI][PubMed]
  • 6. Eggimann P, Garbino J, Pittet D. Epidemiology of Candida species infections in critically ill non-immunosuppressed patients. Lancet Infect Dis. 2003; 3(11): 685-702[PubMed]
  • 7. Hope W, Morton A, Eisen DP. Increase in prevalence of nosocomial non-Candida albicans candidaemia and the association of Candida krusei with fluconazole use. J Hosp Infect. 2002; 50(1): 56-65[DOI][PubMed]
  • 8. Wahyuningsih R, Freisleben HJ, Sonntag HG, Schnitzler P. Simple and rapid detection of Candida albicans DNA in serum by PCR for diagnosis of invasive candidiasis. J Clin Microbiol. 2000; 38(8): 3016-21[PubMed]
  • 9. Marinho SA, Teixeira AB, Santos OS, Cazanova RF, Ferreira CA, Cherubini K, et al. Identification of Candida spp. by phenotypic tests and PCR. Braz J Microbiol. 2010; 41(2): 286-94[DOI][PubMed]
  • 10. Richardson MD. Changing patterns and trends in systemic fungal infections. J Antimicrob Chemother. 2005; 56 Suppl 1[DOI][PubMed]
  • 11. Francuzik W, Skłodowska A, Adamska K, Adamski Z, Tamowicz B, Mikstacki A. Prevalence of yeast fungal infections in intensive care unit in Poland. PeerJ PrePrints. 2015;
  • 12. Mirhendi H, Makimura K, Zomorodian K, Maeda N, Ohshima T, Yamaguchi H. Differentiation of Candida albicans and Candida dubliniensis using a single-enzyme PCR-RFLP method. Jpn J Infect Dis. 2005; 58(4): 235-7[PubMed]
  • 13. Kanbe T, Horii T, Arishima T, Ozeki M, Kikuchi A. PCR-based identification of pathogenic Candida species using primer mixes specific to Candida DNA topoisomerase II genes. Yeast. 2002; 19(11): 973-89[DOI][PubMed]
  • 14. Bourgeois N, Dehandschoewercker L, Bertout S, Bousquet PJ, Rispail P, Lachaud L. Antifungal susceptibility of 205 Candida spp. isolated primarily during invasive Candidiasis and comparison of the Vitek 2 system with the CLSI broth microdilution and Etest methods. J Clin Microbiol. 2010; 48(1): 154-61[DOI][PubMed]
  • 15. Tortorano AM, Dho G, Prigitano A, Breda G, Grancini A, Emmi V, et al. Invasive fungal infections in the intensive care unit: a multicentre, prospective, observational study in Italy (2006-2008). Mycoses. 2012; 55(1): 73-9[DOI][PubMed]
  • 16. Dimopoulos G, Velegraki A, Falagas ME. A 10-year survey of antifungal susceptibility of candidemia isolates from intensive care unit patients in Greece. Antimicrob Agents Chemother. 2009; 53(3): 1242-4[DOI][PubMed]
  • 17. Ahmad S, Khan Z, Mustafa AS, Khan ZU. Epidemiology of Candida colonization in an intensive care unit of a teaching hospital in Kuwait. Med Mycol. 2003; 41(6): 487-93[PubMed]
  • 18. Alvarez-Lerma F, Nolla-Salas J, Leon C, Palomar M, Jorda R, Carrasco N, et al. Candiduria in critically ill patients admitted to intensive care medical units. Intensive Care Med. 2003; 29(7): 1069-76[DOI][PubMed]
  • 19. Khan ZU, Chandy R, Metwali KE. Candida albicans strain carriage in patients and nursing staff of an intensive care unit: a study of morphotypes and resistotypes. Mycoses. 2003; 46(11-12): 479-86[PubMed]
  • 20. Guery BP, Arendrup MC, Auzinger G, Azoulay E, Borges Sa M, Johnson EM, et al. Management of invasive candidiasis and candidemia in adult non-neutropenic intensive care unit patients: Part I. Epidemiology and diagnosis. Intensive Care Med. 2009; 35(1): 55-62[DOI][PubMed]
  • 21. St-Germain G, Lavendie re M, Pelletier R. Prevalence and antifungal susceptibility of 442 Candida isolates from blood and normally sterile sites: results of a 2-year (1996 to 1998) multicenter surveillance study in Quebec, Canada. . J Clin Microbiol. 2001; 39: 949-53
  • 22. Levy I, Rubin LG, Vasishtha S, Tucci V, Sood SK. Emergence of Candida parapsilosis as the predominant species causing candidemia in children. Clin Infect Dis. 1998; 26(5): 1086-8[PubMed]
  • 23. MacDonald L, Baker C, Chenoweth C. Risk factors for candidemia in a children's hospital. Clin Infect Dis. 1998; 26(3): 642-5[PubMed]
  • 24. Sobel JD, Vazquez JA. Fungal infections of the urinary tract. World J Urol. 1999; 17(6): 410-4[PubMed]
  • 25. Fisher JF, Chew WH, Shadomy S, Duma RJ, Mayhall CG, House WC. Urinary tract infections due to Candida albicans. Rev Infect Dis. 1982; 4(6): 1107-18[PubMed]
  • 26. Iman KB, Shorouk KEH, Muhmoud M. Candida infection associated with urinary catheter in critically ill patients. Identification, antifungal susceptibility and risk factors. Res. J Med Sci. 2010; 5(1): 79-86
  • 27. Passos XS, Sales WS, Maciel PJ, Costa CR, Miranda KC, Lemos Jde A, et al. Candida colonization in intensive care unit patients' urine. Mem Inst Oswaldo Cruz. 2005; 100(8): 925-8[PubMed]
  • 28. Colombo AL, Nakagawa Z, Valdetaro F, Branchini ML, Kussano EJ, Nucci M. Susceptibility profile of 200 bloodstream isolates of Candida spp. collected from Brazilian tertiary care hospitals. Med Mycol. 2003; 41(3): 235-9[PubMed]
  • 29. Nucci M. Candiduria in hospitalized patients: a review. Braz J Infect Dis. 2000; 4(4): 168-72[PubMed]
  • 30. Occhipinti DJ, Gubbins PO, Schreckenberger P, Danziger LH. Frequency, pathogenicity and microbiologic outcome of non-Candida albicans candiduria. Eur J Clin Microbiol Infect Dis. 1994; 13(6): 459-67[PubMed]
  • 31. Morace G, Manzara S, Dettori G. In vitro susceptibility of 119 yeast isolates to fluconazole, 5-fluorocytosine, amphotericin B and ketoconazole. Chemotherapy. 1991; 37(1): 23-31[PubMed]
  • 32. Hoppe JE, Klingebiel T, Niethammer D. Selection of Candida glabrata in pediatric bone marrow transplant recipients receiving fluconazole. Pediatr Hematol Oncol. 1994; 11(2): 207-10[PubMed]
  • 33. Nenoff P, Oswald U, Haustein UF. In vitro susceptibility of yeasts for fluconazole and itraconazole. Evaluation of a microdilution test. Mycoses. 1999; 42(11-12): 629-39[PubMed]
  • 34. Lipsett PA. Surgical critical care: fungal infections in surgical patients. Crit Care Med. 2006; 34(9 Suppl)-24[DOI][PubMed]
  • 35. Mean M, Marchetti O, Calandra T. Bench-to-bedside review: Candida infections in the intensive care unit. Crit Care. 2008; 12(1): 204[DOI][PubMed]
  • 36. Zilberberg MD, Shorr AF. Fungal infections in the ICU. Infect Dis Clin North Am. 2009; 23(3): 625-42[DOI][PubMed]
  • 37. Pfaller MA, Diekema DJ, Jones RN, Sader HS, Fluit AC, Hollis RJ, et al. International surveillance of bloodstream infections due to Candida species: frequency of occurrence and in vitro susceptibilities to fluconazole, ravuconazole, and voriconazole of isolates collected from 1997 through 1999 in the SENTRY antimicrobial surveillance program. J Clin Microbiol. 2001; 39(9): 3254-9[PubMed]
  • 38. Rodero L, Davel G, Cordoba S, Soria M, Canteros C, Hochenfellner F. [Multicenter study on nosocomial candidiasis in the Republic of Argentina]. Rev Argent Microbiol. 1999; 31(3): 114-9[PubMed]
  • 39. Alvarado D, Di az MC, Silva V. Identification and antifungal susceptibility of Candida spp. isolated from invasive mycosis. Influence of growth inhibition percentage to determine minimal inhibitory concentration. J Rev Med Chile. 2002; 130: 416-23
  • 40. Sandven P, Bevanger L, Digranes A, Gaustad P, Haukland HH, Steinbakk M. Constant low rate of fungemia in norway, 1991 to 1996. The Norwegian Yeast Study Group. J Clin Microbiol. 1998; 36(12): 3455-9[PubMed]
  • 41. Girmenia C, Martino P, De Bernardis F. Rising incidence of Candida parapsilosis fungemia in patients with hematologic malignancies: clinical aspects, predisposing factors, and differential pathogenicity of the causative strains. J Clin Infect Dis. 1996; 23: 506-14
  • 42. Nolla-Salas J, Sitges-Serra A, Leon-Gil C, Martinez-Gonzalez J, Leon-Regidor MA, Ibanez-Lucia P, et al. Candidemia in non-neutropenic critically ill patients: analysis of prognostic factors and assessment of systemic antifungal therapy. Study Group of Fungal Infection in the ICU. Intensive Care Med. 1997; 23(1): 23-30[PubMed]
  • 43. Badiee P, Alborzi A, Davarpanah MA, Shakiba E. Distributions and antifungal susceptibility of Candida species from mucosal sites in HIV positive patients. Arch Iran Med. 2010; 13(4): 282-7[PubMed]
  • 44. Badiee P, Alborzi A, Shakiba E. Molecular identification and in-vitro susceptibility of Candida albicans and Candida dubliniensis isolated from immunocompromised patients. J Iranian Red Cres Med. 2009; 11: 391-7
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments